Vaccines and Preventable Diseases:
Human Papillomavirus (HPV)
Human Papillomavirus (HPV) is a common virus that is spread through sexual contact. Most of the time HPV has no symptoms so people do not know they have it.
There are approximately 40 types of genital HPV. Somes types can cause cervical cancer in women and can also cause other kinds of cancer in both men and women. Other types can cause genital warts in both males and females. The HPV vaccine works by preventing the most common types of HPV that cause cervical cancer and genital warts. It is given as a 3-dose vaccine.
What You Should Know:
For Health Professionals:
For the Media:
What You Should Know
- Genital HPV Infection
Statistics, treatment, resources, facts, etc.
- Cervical Cancer
Explains what cervical cancer is and describes the Pap Test
- HPV Infection Fact Sheet for the Public
Includes Q&A about genital warts, cancer, etc.
- Pictures of HPV
Warning: Some of these photos might be unsuitable for children. Viewing discretion is advised.
At A Glance: The HPV vaccine is routinely recommended for girls 11 and 12 years of age and is given in a series of three injections over a six-month period. The second and third doses should be given two and six months (respectively) after the first dose.
The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger. HPV vaccine may be given at the same time as other vaccines.
- Questions & Answers about HPV Vaccine
- Side Effects
- Vaccine Information Statement (VIS)
- School Vaccine Requirements
As with all vaccines, there can be minor reactions, including pain and redness at the injection site, headache, fatigue or a vague feeling of discomfort.
- Qs and As for the Public on the Safety and Effectiveness of HPV Vaccine
July 17 UPDATED
- CDC's Vaccine Safety website
For Health Professionals
- Brochure--HPV Information for Clinicians
- Clinicans’ resources on Genital HPV Infection
- HPV & HPV Vaccine - Info for Healthcare Providers
- Ask the Experts (exit)
CDC experts (medial officers, medical epidemiologists, etc.)
- ACIP recommendations
- CDC Statement on the Cost-Effectiveness of HPV Vaccine NEW August 28
- Standing Orders (exit)
- ACIP - Vaccines for Children (VFC) Resolution
- Fast facts that address statements made in a press release by the National Vaccine Information Center on 08/15/07 regarding Gardasil and Guillain-Barre Syndrome (GBS) (47KB/2 pages) (text-only) (7KB/1 page)
- Questions and Answers about HPV Vaccine Safety & Efficacy (29 KB/3 pages) (text-only) (9KB/1 page)
- Pre-teen Vaccine Campaign materials
(Posters, flyers, web banners and web buttons)
- Netconference: Human Papillomavirus (HPV), Cervical Cancer, and HPV Vaccine Recommendations
Archived netconference for clinicans
- Continuing Education (CE) Activity expires 3/23/09
CE for MMWR ACIP Recommendation report on March 23, 2007, in Vol. 56, No. RR-2.
- Human Papillomavirus
Brochure: Info for Clinicians
Brochure on transmission, prevention, detection & clinical management of HPV
- Webcast: HPV & Cervical Cancer: An Update on Prevention Strategies August, 9, 2005
- Recorded broadcast: HPV: The Disease and Vaccine
- Educator's resources
- Podcasts on subject of Vaccines & Immunizations
- Vaccine Information Statement (VIS)
- HPV and Pre-teen Vaccine Campaign Flyers and Posters
- Common Questions about HPV & Cervical Cancer for Women who Have HPV
- Genital HPV--Common Infection Common Reality
- What Every Woman Should Know About Cervical Cancer & HPV (exit)
American Cancer Society (ACS) fact sheet
For the Media
- HPV Vaccine Safety Update, Presentation to the ACIP (153 KB/36 pages) (text-only) (35 KB/1 page) June 28, 2007
- Questions and Answers about HPV Vaccine Safety & Efficacy (29 KB/3 pages) (text-only) (9 KB/1 page) June 7, 2007
- CDC’s Advisory Committee Recommends Human Papillomavirus Virus Vaccination
Media advisory, June 28, 2006
- CDC Signs Federal Contract for HPV Vaccine (exit)
Licenses New Vaccine for Prevention of Cervical
Cancer and Other Diseases in Females Caused by
FDA media release (June 8, 2006)
- GARDASIL® Questions
and Answers (exit)
Product Approval Information from FDA (June 8, 2006)
- Report to Congress: Prevention of Genital Human Papillomavirus Infection (207 KB/35 pages) (exit) (January 2004)
Non-CDC Link Disclaimer: Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization web pages found at these links.
.pdf files: To view and print the .pdf files on this site, you will need Adobe Acrobat Reader. Use this link to obtain a free copy of Adobe Acrobat Reader (exit). We highly recommend that you upgrade to the latest version if haven't already.
Content last reviewed on June 1, 2007
Content Source: National Center for Immunization and Respiratory Diseases